济南男人为啥割包皮(济南龟头敏感射的早) (今日更新中)

SAN FRANCISCO, May 11 (Xinhua) -- Google on Wednesday introduced a series of notebook computers based on its Chrome operating system, stepping up its competition against Microsoft.Google unveiled the "Chromebook" at its annual developers conference in San Francisco, saying that the new devices, made by Acer and Samsung Electronics, will go on sale on June 15 in the United States and six European countries.Google said Chromebooks can boot in 8 seconds and its security system makes it require no virus protection. Applications, documents and setting will be stored in "the cloud," which enables users to have same experience after logging into another Chromebook. The system will get updated automatically with no update prompts.Acer's Chromebook will start at 349 U.S. dollars and Samsung's product will be priced at 429 dollars for its WiFi model and 499 dollars for 3G connectivity. The devices will be available online in the United States through Amazon.com and Best Buy's online store.Google on Wednesday also announced Chromebooks for Business and Education, a subscription service including Chromebooks and a cloud management console to remotely administer and manage users, devices applications and policies.Google said it will directly handle the business and education orders. The monthly fee will be 28 dollars per user for businesses and 20 dollars per user for educational customers.The Chrome operating system, announced in July 2009, is designed to work exclusively with web applications, with its work based on Google's Chrome web browser.On Wednesday's conference, Google said the Chrome web browser now has 160 million active users, compared to 70 million last May.

SANAA, Feb. 5 (Xinhua) -- The Somali pirates hijacked a Chinese-flagged commercial ship off Yemen's western city port of al- Hudaida in the Red Sea, Chinese military attache to Yemen confirmed to Xinhua on Saturday.The Chinese military confirmed that the Chinese-flagged commercial ship, which was registered in Hongkong, China, had been hijacked by the Somali pirates off the Yemeni coast, Chinese military attache to Yemen told Xinhua.The ship was then moved by the pirates towards the Somali coasts, he added, without providing how many people were on board or the date of the hijack.Earlier, Yemeni Interior Ministry said the Chinese ship called "Tien Hau" was attacked by the pirates some 11 nautical miles (20. 4 kilometers) off the Yemeni island of Al-Tair off the city port of al-Hudaida.Meanwhile, a security source at the ministry told Xinhua "the security operation room of the ministry received unconfirmed information that an anti-piracy international navy fleet might intercept the pirates and help release the Chinese ship.""We are following up the situation to confirm the release of the Chinese ship, as coast guard boats were dispatched to track the ship and pirates," he told Xinhua on condition of anonymity."The hijack took place early today, but we do not have exact information about the number of the ship's crew," he added.The Gulf of Aden is considered as one of the world's most dangerous waters because of rampant piracy.

WASHINGTON, April 6 (Xinhua) -- A study led by researchers at the University of Michigan (U-M) showed in animal studies that new cancer drug compounds they developed shrank tumors, with few side effects.The study, done in two mouse models of human cancer, looked at two compounds designed to activate a protein that kills cancer cells. The protein, p53, is inactivated in a significant number of human cancers. In some cases, it is because another protein, MDM2, binds to p53 and blocks its tumor suppresser function. This allows the tumor to grow unchecked. The new compounds block MDM2 from binding to p53, consequently activating p53."For the first time, we showed that activation of p53 by our highly potent and optimized MDM2 inhibitors can achieve complete tumor regression in a mouse model of human cancer," says lead study author Shaomeng Wang, director of the Cancer Drug Discovery Program at the U-M Comprehensive Cancer Center.Wang presented the study Wednesday at the American Association for Cancer Research 102nd annual meeting.Many traditional cancer drugs also activate p53 but they do so by causing DNA damage in both tumor cells and normal cells, causing side effects. These new MDM2 inhibitors activate p53 while avoiding the DNA damage common with other drugs. In this study, which was done in collaboration with Ascenta Therapeutics and Sanonfi-Aventis, researchers showed that these new drugs shrank tumors without significant side effects.Because p53 is involved in all types of human cancer, the new drug has potential to be used in multiple types of cancer. Further, the researchers also identified certain markers in tumors that predict which ones will be particularly sensitive to the MDM2 inhibitor, which would allow physicians to target the drug only to patients most likely to benefit.

BEIJING, March 24 (Xinhuanet) -- A new study has found that Actos, a medicine treats onset diabetes, could also reduce the diabetes risk in people with prediabetes.The study, which was published Wednesday in New England Journal of Medicine, followed 602 prediabetics whose obesity, ethnicity, family history and other factors put them at high risk of developing diabetes.The research findings showed that Actos, generically known as pioglitazone, reduced the odds of developing Type 2 diabetes by 72 percent in people with prediabetes.Only 2.1 percent of those who took Actos developed diabetes each year over the three years of the study, compared with 7.6 percent of those who took a placebo.Lead author of the study Ralph DeFronzo said, "The 72 percent reduction is the largest decrease in the conversion rate of pre-diabetes to (Type 2) diabetes that has ever been demonstrated by any intervention, be it diet, exercise or medication."However, Actos can have significant side effects, including water retention, moderate weight gain, and increased risk of bone fractures.

BEIJING, Feb. 5 (Xinhua) -- Lending to China's small and medium-sized enterprises (SMEs) rose faster than loans to large enterprises last year, according to the People's Bank of China (PBOC), the central bank.Outstanding loans to small enterprises by banks and financial institutions jumped 29.3 percent year on year to 7.55 trillion yuan (1.15 trillion U.S. dollars) in 2010, while loans to medium-sized enterprises stood at 10.13 trillion yuan, up 17.8 percent, said the PBOC.Outstanding loans to large enterprises rose 13.3 percent to 13.42 trillion yuan, highlighting the government's efforts to optimize the loan structure, the PBOC said.About 99 percent of Chinese enterprises are SMEs which contribute 60 percent of the country's gross domestic product.Financing has long been difficult for Chinese SMEs as banks prefer to lend to big companies, particularly reputable state-owned enterprises.The government has moved to help SMEs get finance by differentiating the reserve requirement ratio for the Rural Credit Cooperative, the major lender to SMEs, and encouraging innovation in SME bond issuance.In July last year, the PBOC asked financial institutions to establish independent criteria for approving loans to SMEs and to improve efficiency in processing SME loan applications.The PBOC said SME loan growth would continue to accelerate this year.

来源：资阳报